34181511000001103: Ellanite 0.03mg/3mg tablets (Kent Pharma (UK) Ltd) (product)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Actual medicinal product\Ellanite 0.03mg/3mg tablets (Kent Pharma (UK) Ltd)
\UK product\Virtual medicinal product\Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet\Ellanite 0.03mg/3mg tablets (Kent Pharma (UK) Ltd)
\UK product\Virtual therapeutic moiety\Ethinylestradiol + Drospirenone\Product containing only drospirenone and ethinylestradiol in oral dose form (medicinal product form)\Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet\Ellanite 0.03mg/3mg tablets (Kent Pharma (UK) Ltd)
\UK product\Virtual therapeutic moiety\Ethinylestradiol + Drospirenone\Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet\Ellanite 0.03mg/3mg tablets (Kent Pharma (UK) Ltd)
\UK product\Trade family\Ellanite\Ellanite 0.03mg/3mg tablets (Kent Pharma (UK) Ltd)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Apr 2017. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

2877671000001112 Ellanite 0.03mg/3mg tablets (Kent Pharma (UK) Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

2877681000001114 Ellanite 0.03mg/3mg tablets (Kent Pharma (UK) Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Ellanite 0.03mg/3mg tablets (Kent Pharma (UK) Ltd)	Has excipient	Excipient not declared	true	Inferred relationship	Existential restriction modifier
Ellanite 0.03mg/3mg tablets (Kent Pharma (UK) Ltd)	Has NHS dm+d (dictionary of medicines and devices) controlled drug category	Controlled drug category No Controlled Drug Status	true	Inferred relationship	Existential restriction modifier
Ellanite 0.03mg/3mg tablets (Kent Pharma (UK) Ltd)	Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator	NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available	true	Inferred relationship	Existential restriction modifier
Ellanite 0.03mg/3mg tablets (Kent Pharma (UK) Ltd)	Is a	Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet	true	Inferred relationship	Existential restriction modifier
Ellanite 0.03mg/3mg tablets (Kent Pharma (UK) Ltd)	Has active ingredient	Ethinylestradiol	false	Inferred relationship	Existential restriction modifier
Ellanite 0.03mg/3mg tablets (Kent Pharma (UK) Ltd)	Has active ingredient	Drospirenone	false	Inferred relationship	Existential restriction modifier
Ellanite 0.03mg/3mg tablets (Kent Pharma (UK) Ltd)	Has manufactured dose form	Conventional release oral tablet	true	Inferred relationship	Existential restriction modifier
Ellanite 0.03mg/3mg tablets (Kent Pharma (UK) Ltd)	VMP prescribing status (attribute)	VMP valid as a prescribable product	true	Inferred relationship	Existential restriction modifier
Ellanite 0.03mg/3mg tablets (Kent Pharma (UK) Ltd)	VMP non-availability indicator	Available	true	Inferred relationship	Existential restriction modifier
Ellanite 0.03mg/3mg tablets (Kent Pharma (UK) Ltd)	Has specific active ingredient	Ethinylestradiol	true	Inferred relationship	Existential restriction modifier
Ellanite 0.03mg/3mg tablets (Kent Pharma (UK) Ltd)	Has specific active ingredient	Drospirenone	true	Inferred relationship	Existential restriction modifier
Ellanite 0.03mg/3mg tablets (Kent Pharma (UK) Ltd)	Has dispensed dose form	Tablet	true	Inferred relationship	Existential restriction modifier
Ellanite 0.03mg/3mg tablets (Kent Pharma (UK) Ltd)	Has excipient	Lactose	false	Inferred relationship	Existential restriction modifier
Ellanite 0.03mg/3mg tablets (Kent Pharma (UK) Ltd)	Is a	Actual medicinal product	true	Inferred relationship	Existential restriction modifier
Ellanite 0.03mg/3mg tablets (Kent Pharma (UK) Ltd)	Is a	Ellanite	true	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Ellanite 0.03mg/3mg tablets (Kent Pharma (UK) Ltd) 63 tablet 3 x 21 tablets	Has AMP	True	Ellanite 0.03mg/3mg tablets (Kent Pharma (UK) Ltd)	Inferred relationship	Existential restriction modifier
Ellanite 0.03mg/3mg tablets (Kent Pharma (UK) Ltd) 21 tablet	Has AMP	True	Ellanite 0.03mg/3mg tablets (Kent Pharma (UK) Ltd)	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
2877671000001112	Ellanite 0.03mg/3mg tablets (Kent Pharma (UK) Ltd)	en	Synonym	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module
2877681000001114	Ellanite 0.03mg/3mg tablets (Kent Pharma (UK) Ltd) (product)	en	Fully specified name	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module